Christopher Anderson

Mr. Anderson is a member of Kohlberg’s Investment Committee and is responsible for leading the Healthcare practice area. In addition to his investing responsibilities, Mr. Anderson also contributes to developing the Firm’s investment strategy and coordinates practice area development and engagement. Mr. Anderson joined Kohlberg in 1998, was named a Partner in 2005 and a Senior Partner in 2024. Prior to joining the Firm, Mr. Anderson was with Warburg Dillon Read. He is a member of the board of directors of Cadence, Elevate Outdoor Collective, Nelipak, PCI Pharma Services, Spinal Elements, Trinity Life Sciences and Worldwide Clinical Trials. Mr. Anderson received a B.A. from Princeton University.